ClinicalTrials.gov record
Recruiting Phase 3 Interventional

A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)

ClinicalTrials.gov ID: NCT06760546

Public ClinicalTrials.gov record NCT06760546. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 11:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Double Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Setmelanotide in Patients With Acquired Hypothalamic Obesity

Study identification

NCT ID
NCT06760546
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Rhythm Pharmaceuticals, Inc.
Industry
Enrollment
39 participants

Conditions and interventions

Eligibility (public fields only)

Age range
4 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 22, 2025
Primary completion
Mar 12, 2027
Completion
Mar 12, 2028
Last update posted
Feb 11, 2026

2025 – 2028

United States locations

U.S. sites
8
U.S. states
8
U.S. cities
8
Facility City State ZIP Site status
University of Alabama Birmingham Alabama 35233 Recruiting
Children's Hospital Colorado Aurora Colorado 80045 Recruiting
Lurie Children's Hospital Chicago Illinois 60611 Recruiting
Boston Children's Hospital Boston Massachusetts 02115 Recruiting
Children's Minnesota Saint Paul Minnesota 55102 Recruiting
Columbia University Irving Medical Center New York New York 10032 Recruiting
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 Recruiting
Seattle Children's Research Institute Seattle Washington 98105 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06760546, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 11, 2026 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06760546 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →